247 related articles for article (PubMed ID: 28663097)
1. Interleukin 17A in atherosclerosis - Regulation and pathophysiologic effector function.
Nordlohne J; von Vietinghoff S
Cytokine; 2019 Oct; 122():154089. PubMed ID: 28663097
[TBL] [Abstract][Full Text] [Related]
2. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
Erbel C; Akhavanpoor M; Okuyucu D; Wangler S; Dietz A; Zhao L; Stellos K; Little KM; Lasitschka F; Doesch A; Hakimi M; Dengler TJ; Giese T; Blessing E; Katus HA; Gleissner CA
J Immunol; 2014 Nov; 193(9):4344-55. PubMed ID: 25261478
[TBL] [Abstract][Full Text] [Related]
3. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
4. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.
Ge S; Hertel B; Koltsova EK; Sörensen-Zender I; Kielstein JT; Ley K; Haller H; von Vietinghoff S
Circ Res; 2013 Sep; 113(8):965-74. PubMed ID: 23908345
[TBL] [Abstract][Full Text] [Related]
5. The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.
Butcher MJ; Gjurich BN; Phillips T; Galkina EV
Circ Res; 2012 Mar; 110(5):675-87. PubMed ID: 22302786
[TBL] [Abstract][Full Text] [Related]
6. The Two Faces of Interleukin-17A in Atherosclerosis.
Akhavanpoor M; Akhavanpoor H; Gleissner CA; Wangler S; Doesch AO; Katus HA; Erbel C
Curr Drug Targets; 2017; 18(7):863-873. PubMed ID: 28034277
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
[TBL] [Abstract][Full Text] [Related]
8. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.
Smith E; Prasad KM; Butcher M; Dobrian A; Kolls JK; Ley K; Galkina E
Circulation; 2010 Apr; 121(15):1746-55. PubMed ID: 20368519
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A Promotes Aortic Endothelial Cell Activation via Transcriptionally and Post-translationally Activating p38 Mitogen-activated Protein Kinase (MAPK) Pathway.
Mai J; Nanayakkara G; Lopez-Pastrana J; Li X; Li YF; Wang X; Song A; Virtue A; Shao Y; Shan H; Liu F; Autieri MV; Kunapuli SP; Iwakura Y; Jiang X; Wang H; Yang XF
J Biol Chem; 2016 Mar; 291(10):4939-54. PubMed ID: 26733204
[TBL] [Abstract][Full Text] [Related]
10. Current views on the functions of interleukin-17A-producing cells in atherosclerosis.
Butcher M; Galkina E
Thromb Haemost; 2011 Nov; 106(5):787-95. PubMed ID: 21946932
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A in lipid metabolism and atherosclerosis.
Yu XH; Jiang N; Zheng XL; Cayabyab FS; Tang ZB; Tang CK
Clin Chim Acta; 2014 Apr; 431():33-9. PubMed ID: 24508995
[TBL] [Abstract][Full Text] [Related]
12. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.
Erbel C; Dengler TJ; Wangler S; Lasitschka F; Bea F; Wambsganss N; Hakimi M; Böckler D; Katus HA; Gleissner CA
Basic Res Cardiol; 2011 Jan; 106(1):125-34. PubMed ID: 21116822
[TBL] [Abstract][Full Text] [Related]
13. Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A.
Salvatore G; Bernoud-Hubac N; Bissay N; Debard C; Daira P; Meugnier E; Proamer F; Hanau D; Vidal H; Aricò M; Delprat C; Mahtouk K
J Lipid Res; 2015 Jun; 56(6):1110-22. PubMed ID: 25833686
[TBL] [Abstract][Full Text] [Related]
14. The Biological Effects of Interleukin-17A on Adhesion Molecules Expression and Foam Cell Formation in Atherosclerotic Lesions.
Shiotsugu S; Okinaga T; Habu M; Yoshiga D; Yoshioka I; Nishihara T; Ariyoshi W
J Interferon Cytokine Res; 2019 Nov; 39(11):694-702. PubMed ID: 31361541
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K
Circ Res; 2012 Oct; 111(10):1274-85. PubMed ID: 22927332
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-23 receptor expressing γδ T cells locally promote early atherosclerotic lesion formation and plaque necrosis in mice.
Gil-Pulido J; Amézaga N; Jorgacevic I; Manthey HD; Rösch M; Brand T; Cidlinsky P; Schäfer S; Beilhack A; Saliba AE; Lorenz K; Boon L; Prinz I; Waisman A; Korn T; Cochain C; Zernecke A
Cardiovasc Res; 2022 Nov; 118(14):2932-2945. PubMed ID: 34897380
[TBL] [Abstract][Full Text] [Related]
17. IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.
Chen S; Shimada K; Zhang W; Huang G; Crother TR; Arditi M
J Immunol; 2010 Nov; 185(9):5619-27. PubMed ID: 20935201
[TBL] [Abstract][Full Text] [Related]
18. Structure and signalling in the IL-17 receptor family.
Gaffen SL
Nat Rev Immunol; 2009 Aug; 9(8):556-67. PubMed ID: 19575028
[TBL] [Abstract][Full Text] [Related]
19. Identification of heterogeneous subsets of aortic interleukin-17A-expressing CD4
Lin G; Zhang L; Yan Z; Jiang W; Wu B; Li D; Xiong X
Int J Immunopathol Pharmacol; 2022; 36():3946320221117933. PubMed ID: 35932160
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway.
Gisterå A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK
Sci Transl Med; 2013 Jul; 5(196):196ra100. PubMed ID: 23903754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
